# Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

> **NCT00002231** · PHASE1 · COMPLETED · sponsor: **Wyeth-Lederle Vaccines**

## Conditions studied

- HIV Infections
- HIV Seronegativity

## Interventions

- **BIOLOGICAL:** APL 400-003

## Key facts

- **NCT ID:** NCT00002231
- **Lead sponsor:** Wyeth-Lederle Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002231, "Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00002231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*